Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, Rebecca S. Heist et al.|Cancer Discovery|2019Cited by 238
Abstract 2972: Co-clinical trial of olaparib and temozolomide in SCLC PDX models uncovers new biomarkers of sensitivityBenjamin J. Drapkin, Nicholas J. Dyson, Julie George et al.|Cancer Research|2018Cited by 1